The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trials of cetuximab plus combined modality therapy (CMT) in squamous cell carcinoma of the anal canal (SCCAC) with and without human immunodeficiency virus (HIV) infection.
 
Madhur Garg
No Relationships to Disclose
 
Fengmin Zhao
No Relationships to Disclose
 
Jeannette Y. Lee
No Relationships to Disclose
 
Joseph A. Sparano
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - AstraZeneca; Celgene; Curis; Eisai; Genentech/Roche; Johnson & Johnson; Novartis; Sanofi
Research Funding - Merck (Inst)
 
Joel Palefsky
No Relationships to Disclose
 
David H. Henry
Honoraria - AMAG Pharmaceuticals; Amgen
Consulting or Advisory Role - AMAG Pharmaceuticals; Amgen
Research Funding - Amgen
Travel, Accommodations, Expenses - AMAG Pharmaceuticals; Amgen
 
William Wachsman
No Relationships to Disclose
 
Lakshmi Rajdev
No Relationships to Disclose
 
David Michael Aboulafia
No Relationships to Disclose
 
Lee Ratner
No Relationships to Disclose
 
Lisa A. Kachnic
Consulting or Advisory Role - Best Doctors, Inc
Patents, Royalties, Other Intellectual Property - UpToDate
 
Edith P. Mitchell
Honoraria - Sanofi
Consulting or Advisory Role - Genentech
Research Funding - Genentech (Inst); sanofi (Inst)
 
Adedayo A. Onitilo
No Relationships to Disclose
 
Ronald T. Mitsuyasu
Stock and Other Ownership Interests - Amgen
Research Funding - Calimmune (Inst); Sangamo Bioscience (Inst)
 
Al Bowen Benson
Consulting or Advisory Role - Alchemia; Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech/Roche; Genomic Health; Infinity Pharmaceuticals; Lilly/ImClone; Merck Serono; Merck/Schering Plough; National Cancer Institute; Pharmacyclics; Precision Therapeutics; Sanofi; Spectrum Pharmaceuticals; Taiho Pharmaceutical; Vicus Therapeutics
Research Funding - advanced accelerator applications; Alchemia; Amgen; Astellas Pharma; AVEO; Bayer/Onyx; EMD Serono (Inst); Genentech (I); Gilead Sciences; Infinity Pharmaceuticals; Merck Serono (Inst); Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AVEO; Bayer; Genentech/Roche; Gilead Sciences; Lilly/ImClone; Sanofi; Spectrum Pharmaceuticals